Number of Manufacturers and Generic Drug Pricing From 2005 to 2017
Regardless of the number of manufacturers, generic drug prices presented double-digit average increases from 2012 to 2015.
Medicaid Prior Authorization and Opioid Medication Abuse and Overdose
Enrollees in Medicaid plans employing prior authorization policies for opioid medications may have lower rates of opioid medication abuse and overdose.
Long-Term Outcomes of Analogue Insulin Compared With NPH for Patients With Type 2 Diabetes Mellitus
There were no significant differences in the risk of ambulatory care—sensitive condition hospitalization or mortality between patients who initiated analogue insulin compared with the neutral protamine Hagedorn.
Assessing the Chiral Switch: Approval and Use of Single-Enantiomer Drugs, 2001 to 2011
From 2001 to 2011, the US Food and Drug Administration approved 9 single-enantiomer drugs with racemic precursors. None showed pre-approval evidence of improved efficacy over the racemic precursor.
Medicare Part D and Potentially Inappropriate Medication Use in the Elderly
High-risk drug use increased slightly among seniors gaining Medicare Part D coverage; however, high-risk drugs account for a small share of total drug use.
Variation in Prescription Use and Spending for Lipid-Lowering and Diabetes Medications in the Veterans Affairs Healthcare System
Substantial variation in prescription spending and use of brand-name drugs exists across the VA healthcare system, with no apparent relationship to quality of care.
2 Clarke Drive Cranbury, NJ 08512